Does disease activity at start of biologic therapy influence work-loss in RA patients?
(2015) In Rheumatology (Oxford, England)- Abstract
- To compare work-loss in RA patients starting their first biologic with high vs moderate disease activity.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8504275
- author
- Olofsson, Tor O LU ; Johansson, Kari ; Eriksson, Jonas K ; van Vollenhoven, Ronald ; Miller, Heather ; Petersson, Ingemar LU ; Askling, Johan and Neovius, Martin
- organization
- publishing date
- 2015-12-18
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Rheumatology (Oxford, England)
- publisher
- Oxford University Press
- external identifiers
-
- pmid:26683196
- scopus:84963772362
- pmid:26683196
- wos:000374234100019
- ISSN
- 1462-0332
- DOI
- 10.1093/rheumatology/kev407
- language
- English
- LU publication?
- yes
- id
- e25d853b-6575-4eb6-b805-0ccdedcf1159 (old id 8504275)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26683196?dopt=Abstract
- date added to LUP
- 2016-04-04 09:19:24
- date last changed
- 2024-01-27 09:57:54
@article{e25d853b-6575-4eb6-b805-0ccdedcf1159, abstract = {{To compare work-loss in RA patients starting their first biologic with high vs moderate disease activity.}}, author = {{Olofsson, Tor O and Johansson, Kari and Eriksson, Jonas K and van Vollenhoven, Ronald and Miller, Heather and Petersson, Ingemar and Askling, Johan and Neovius, Martin}}, issn = {{1462-0332}}, language = {{eng}}, month = {{12}}, publisher = {{Oxford University Press}}, series = {{Rheumatology (Oxford, England)}}, title = {{Does disease activity at start of biologic therapy influence work-loss in RA patients?}}, url = {{http://dx.doi.org/10.1093/rheumatology/kev407}}, doi = {{10.1093/rheumatology/kev407}}, year = {{2015}}, }